Abstract
A new ex vivo method for assaying adhesion of cancer cells to the greater omentum has been developed using mouse greater omentum and [3H]labelled human gastric and mouse colorectal cancer cells. Since the adhesion rates were found to increase up to 18 h and labelled cells seemed to be stable during the period, the present method could be useful for investigating adhesion of cancer cells to the greater omentum, which must occur at the first step of the peritoneal dissemination. The adhesion of cancer cells to the greater omentum was inhibited by a series of chemically synthesized oligosaccharides and Galβ1,3[3OMeGalβ1,4GlcNAcβ1,6]αBn was found to be the best inhibitor. The anti-tumor effect of this novel tetrasaccharide in vivo was shown in preliminary experiments using Balb/c mice and colon26 cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Albelda SM. Biology of disease. Role of intergrins and other cell adhesion molecules in tumour progression and metastasis. Lab Invest 1993; 68: 4–17.
Gardner MJ, Jones LM, Catterall JB et al. Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis. Cancer Lett 1995; 91: 229–34.
Yashiro M, Chung YS, Nishimura S et al. Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice. Clin Exp Metastasis 1996; 14: 43–54.
Moore GE, Sako K, Koandou T et al. Assessment of the exfoliation of tumor cells into the body cavities. Surg Gynecol Obstet 1961; 122: 469–74.
Fujimoto S, Shrestha RD, Kokubun M et al. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 1988; 208: 36–41.
Yonemura Y et al. Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 1991; 15: 530–6.
Lygidakis NJ, Spentzouris N, Theodoracopoulos M et al. Pancreatic resection for pancreatic carcinoma combined with neo-and adjuvant locoreginal targeting immunochemoteraphy-a prospective randomized study. Hepatogastroenterol 1998; 45: 396–403.
Zhnag M, Yao Z, Saga T et al. Improved intratumoral penetration of radiolabeled streptavidin in intraperitoneal tumors pretargeted with biotinylated antibody. J Nucl Med 1998; 39: 30–3.
Hakomori S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 1996; 56: 5309–18.
Asao T, Yazawa S, Kudo S et al. A novel ex vivo method for assaying adhesion of cancer cells to the peritoneum. Cancer Lett 1994; 78: 57–62.
Asao T, Nagamachi Y, Morinaga N et al. Fucosyltransferases of the peritoneum contributed to the adhesion of cancer cells to the mesothelium. Cancer 1995; 75: 1539–44.
Shimotsuma M, Kawata M, Hagiwara A et al. Milky spots in the human greater omentum. Macroscopic and histological identification. Acta Anat 1989; 136: 211–6.
Hagiwara A, Takahashi T, Sawai K et al. Milky spots as the implantation site for malignant cells in peritoneal dissemination in mice. Cancer Res 1993; 53: 687–92.
Yazawa S, Akamatsu S, Tachikawa T et al. Development and characterization of a novel anti-fucosylated antigen monoclonal antibody YB-2 and its usefulness in the immunohistochemical diagnosis of colorectal cancer. Jpn J Cancer Res 1993; 84: 641–8.
Kannagi R, Fukushi Y, Tachikawa T et al. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine. Cancer Res 1986; 46: 2619–26.
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxity assays. J Immunol Methods 1983; 65: 55–63.
Sakurai Y, Hirohashi S, Shimosato Y et al. Selection of a monoclonal antibody reactive with a high molecular-weight glycoprotein circulating in the body fluid of gastrointestinal cancer patients. Cancer Res 1988; 48: 4053–8.
Nakatani H, Tahara E, Yoshida T et al. Detection of amplified DNA sequences in gastric cancers by a DNA renaturation method in gel. Jpn J Cancer Res 1986; 77: 849–53.
Motoyama T, Hojo H, Watanabe H. Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol Jpn 1986; 36: 65–83.
Baenziger JU, Fiete D. Structural determinants of Ricinus communis agglutinin and toxin specificity for oligosaccharides. J Biol Chem 1979; 254: 9795–9.
Lotan R, Skulelsky E, Danon D et al. The purification, composition and specificity of the anti-T lectin from peanut (Arachis hypogaea). J Biol Chem 1975; 250: 8518–23.
Koenig A, Jain R, Vig R et al. Selectin inhibition: synthesis and evaluation of novel sialylated, sulfated and fucosylated oligosaccharides, including the major capping group of GlyCAM-1. Glycobiology 1997; 7: 79–93.
Jain R, Piskorz CF, Huang BG et al. Inhibition of L-and P-selectin by a rationally synthesized novel core 2-like branched structure containig GalNAc-Lewisx and Neu5Acα2-3Galβ1-3GalNAc sequence. Glycobiology 1998; 8: 707–17.
Phillips ML, Nudelman E, Gaeta FCA et al. ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science 1990; 250: 1130–2.
Walz G, Aruffo A, Kolanus W et al. Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells. Science 1990; 250: 1132–5.
Brandley BK, Swiedler SJ, Robbins PW. Carbohydrate ligands of the LEC cell adhesion molecules. Cell 1990; 63: 861–3.
Berg EL, Robinson MK, Mansson O et al. A carbohydrate domain common to both sialyl Lea and sialyl Lex is recognized by the endothelial cell leukocyte adhesion molecule ELAM-1. J Biol Chem 1991; 266: 14869–72.
Takada A, Ohmori K, Takahashi N et al. Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A. Biochem Biophys Res Commun 1991; 179: 713–9.
Tyrrell D, James P, Rao N et al. Structural requirements for the carbohydrate ligand of E-selectin. Proc Natl Acad Sci USA 1991; 88: 10372–6.
Madiyalakan R, Yazawa S, Abbas SA et al. Use of N-acetyl-2’-O-methyllactosamine as a specific acceptor for the determination of α-L-(1→3)-fucosyltransferase in human serum. Anal Biochem 1986; 152: 22–8.
Yazawa S, Madiyalaka R, Izawa H et al. Cancer-associated elevation of α(1→3)-L-fucosyltransferase activity in human serum. Cancer 1988; 62: 516–20.
Fujita S, Suzuki H, Kinoshita M, Hirohashi S. Inhibition of cell attachment, invasion and metastasis of human carcinoma cells by antiintegrin β1 subunit antibody. Jpn J Cancer Res 1992; 83: 1317–26.
Seiter S, Arch R, Rever S et al. Prevension of tumor metastasis formation by anti-variant CD44. J Exp Med 1993; 177: 443–55.
Gardner MJ, Catterall JB, Jones LM et al. Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: A possible step in peritoneal metastasis. Clin Exp Metastasis 1996; 14: 325–34.
Nakashio T, Narita T, Akiyama S et al. Adhesion molecules and TGF-β1 are involved in the peritoneal dissemination of NUGC-4 human gastric cancer cells. Int J Cancer 1997; 70: 612–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Okamura, A., Yazawa, S., Nishimura, T. et al. A new method for assaying adhesion of cancer cells to the greater omentum and its application for evaluating anti-adhesion activities of chemically synthesized oligosaccharides. Clin Exp Metastasis 18, 37–43 (2000). https://doi.org/10.1023/A:1026526829010
Issue Date:
DOI: https://doi.org/10.1023/A:1026526829010